Preclinical Development of Near-Infrared-Labeled CD38-Targeted Daratumumab for Optical Imaging of CD38 in Multiple Myeloma (vol 23, pg 186, 2020)

被引：0
|
作者：
Cho, Nicholas [1 ,2 ]
Ko, Sooah [2 ]
Shokeen, Monica [1 ,2 ,3 ,4 ]
机构：
[1] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA
[2] Washington Univ St Louis, Dept Biomed Engn, St Louis, MO 63110 USA
[3] Washington Univ, Alvin J Siteman Canc Ctr, Sch Med, St Louis, MO 63110 USA
[4] Barnes Jewish Hosp, St Louis, MO 63110 USA
来源：
MOLECULAR IMAGING AND BIOLOGY | 2025年
关键词：
D O I：
10.1007/s11307-025-01984-8
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页数：3
相关论文
共 25 条
  • [1] Preclinical Development of Near-Infrared-Labeled CD38-Targeted Daratumumab for Optical Imaging of CD38 in Multiple Myeloma
    Cho, Nicholas
    Ko, Sooah
    Shokeen, Monica
    MOLECULAR IMAGING AND BIOLOGY, 2021, 23 (02) : 186 - 195
  • [2] Preclinical Development of CD38-Targeted [89Zr] Zr-DFO-Daratumumab for Imaging Multiple Myeloma
    Ghai, Anchal
    Maji, Dolonchampa
    Cho, Nicholas
    Chanswangphuwana, Chantiya
    Rettig, Michael
    Shen, Duanwen
    DiPersio, John
    Akers, Walter
    Dehdashti, Farrokh
    Achilefu, Samuel
    Vij, Ravi
    Shokeen, Monica
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (02) : 216 - 222
  • [3] CD38-targeted therapy with daratumumab reduces autoantibody levels in multiple myeloma patients
    Frerichs, Kristine A.
    Verkleij, Christie P. M.
    Bosman, Patricia W. C.
    Zweegman, Sonja
    Otten, Henny
    van de Donk, Niels W. C. J.
    JOURNAL OF TRANSLATIONAL AUTOIMMUNITY, 2019, 2
  • [4] Daratumumab Immunopolymersome-Enabled Safe and CD38-Targeted Chemotherapy and Depletion of Multiple Myeloma
    Yu, Na
    Zhang, Yifan
    Li, Jiaying
    Gu, Wenxing
    Yue, Shujing
    Li, Bin
    Meng, Fenghua
    Sun, Huanli
    Haag, Rainer
    Yuan, Jiandong
    Zhong, Zhiyuan
    ADVANCED MATERIALS, 2021, 33 (39)
  • [5] CD38-targeted therapy for multiple myeloma: Mechanisms of action and clinical development
    Kitadate, Akihiro
    ANNALS OF ONCOLOGY, 2022, 33 : S431 - S431
  • [6] Preclinical assessment of 68Ga-labeled CD38 Peptide for PET Imaging of pharmacokinetics in multiple myeloma
    Kang, L.
    Yang, Q.
    Song, L.
    Huang, W.
    Sun, X.
    Wang, T.
    Wang, Z.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S452 - S453
  • [7] 68Ga-labeled CD38 peptide for pharmacokinetic PET imaging in multiple myeloma: a preclinical evaluation
    Kang, Lei
    Yang, Qi
    Song, Lele
    Huang, Wenpeng
    Sun, Xinyao
    Wang, Tianyao
    Wang, Zihua
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [8] 89Zr-DFO-Isatuximab for CD38-Targeted ImmunoPET Imaging of Multiple Myeloma and Lymphomas
    Alvarez, Natalia Herrero
    Michel, Alexa L.
    Viray, Tara D.
    Mayerhoefer, Marius E.
    Lewis, Jason S.
    ACS OMEGA, 2023, 8 (25): : 22486 - 22495
  • [9] Preclinical development of [89Zr]Zr-DFO-Isatuximab as a novel immunoPET tracer for CD38-targeted imaging of multiple myeloma and lymphomas
    Alvarez, Natalia Herrero
    Lewis, Jason
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S192 - S193
  • [10] Synthesis, preclinical analysis, and first-in-human phase I imaging of 89Zr-DFO-daratumumab for CD38 targeted imaging of myeloma
    Ulaner, Gary
    Sobol, Nicholas
    O'Donoghue, Joe
    Lyashchenko, Serge
    Lewis, Jason
    Landgren, C. Ola
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E19 - E19
123